[{"headers": [["CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) shares in Thousands, $ in Millions", "3 Months Ended", "6 Months Ended"], ["Mar. 28, 2020", "Mar. 30, 2019", "Mar. 28, 2020", "Mar. 30, 2019"]], "sections": ["Operating expenses:", "Earnings per share:", "Shares used in computing earnings per share:"], "data": [["Net sales", "$ 58,313", "$ 58,015", "$ 150,132", "$ 142,325"], ["Cost of sales", "35,943", "36,194", "92,545", "88,473"], ["Gross margin", "22,370", "21,821", "57,587", "53,852"], ["Research and development", "4,565", "3,948", "9,016", "7,850"], ["Selling, general and administrative", "4,952", "4,458", "10,149", "9,241"], ["Total operating expenses", "9,517", "8,406", "19,165", "17,091"], ["Operating income", "12,853", "13,415", "38,422", "36,761"], ["Other income/(expense), net", "282", "378", "631", "938"], ["Income before provision for income taxes", "13,135", "13,793", "39,053", "37,699"], ["Provision for income taxes", "1,886", "2,232", "5,568", "6,173"], ["Net income", "$ 11,249", "$ 11,561", "$ 33,485", "$ 31,526"], ["Basic (in dollars per share)", "$ 2.58", "$ 2.47", "$ 7.63", "$ 6.70"], ["Diluted (in dollars per share)", "$ 2.55", "$ 2.46", "$ 7.56", "$ 6.66"], ["Basic (in shares)", "4,360,101", "4,674,071", "4,387,570", "4,704,945"], ["Diluted (in shares)", "4,404,691", "4,700,646", "4,429,648", "4,736,949"], ["Products", "", "", "", ""], ["Net sales", "$ 44,965", "$ 46,565", "$ 124,069", "$ 120,000"], ["Cost of sales", "31,321", "32,047", "83,396", "80,285"], ["Services", "", "", "", ""], ["Net sales", "13,348", "11,450", "26,063", "22,325"], ["Cost of sales", "$ 4,622", "$ 4,147", "$ 9,149", "$ 8,188"]]}, {"headers": [["CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Millions", "Mar. 28, 2020", "Sep. 28, 2019"]], "sections": ["Current assets:", "Non-current assets:", "Current liabilities:", "Non-current liabilities:", "Shareholders\u2019 equity:"], "data": [["Cash and cash equivalents", "$ 40,174", "$ 48,844"], ["Marketable securities", "53,877", "51,713"], ["Accounts receivable, net", "15,722", "22,926"], ["Inventories", "3,334", "4,106"], ["Vendor non-trade receivables", "14,955", "22,878"], ["Other current assets", "15,691", "12,352"], ["Total current assets", "143,753", "162,819"], ["Marketable securities", "98,793", "105,341"], ["Property, plant and equipment, net", "35,889", "37,378"], ["Other non-current assets", "41,965", "32,978"], ["Total non-current assets", "176,647", "175,697"], ["Total assets", "320,400", "338,516"], ["Accounts payable", "32,421", "46,236"], ["Other current liabilities", "37,324", "37,720"], ["Deferred revenue", "5,928", "5,522"], ["Commercial paper and repurchase agreement", "10,029", "5,980"], ["Term debt", "10,392", "10,260"], ["Total current liabilities", "96,094", "105,718"], ["Term debt", "89,086", "91,807"], ["Other non-current liabilities", "56,795", "50,503"], ["Total non-current liabilities", "145,881", "142,310"], ["Total liabilities", "241,975", "248,028"], ["Commitments and contingencies", "", ""], ["Common stock and additional paid-in capital, $0.00001 par value: 12,600,000 shares authorized; 4,323,987 and 4,443,236 shares issued and outstanding, respectively", "48,032", "45,174"], ["Retained earnings", "33,182", "45,898"], ["Accumulated other comprehensive income/(loss)", "(2,789)", "(584)"], ["Total shareholders\u2019 equity", "78,425", "90,488"], ["Total liabilities and shareholders\u2019 equity", "$ 320,400", "$ 338,516"]]}, {"headers": [["CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($) $ in Millions", "Total", "Common stock and additional paid-in capital", "Retained earnings", "Accumulated other comprehensive income/(loss)"]], "sections": ["Increase (Decrease) in Stockholders' Equity [Roll Forward]", "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "Increase (Decrease) in Stockholders' Equity [Roll Forward]"], "data": [["Beginning balances at Sep. 29, 2018", "$ 107,147", "$ 40,201", "$ 70,400", "$ (3,454)"], ["Common stock issued", "", "390", "", ""], ["Common stock withheld related to net share settlement of equity awards", "", "(927)", "(608)", ""], ["Share-based compensation", "", "3,137", "", ""], ["Net income", "31,526", "", "31,526", ""], ["Dividends and dividend equivalents declared", "", "", "(7,025)", ""], ["Common stock repurchased", "", "", "(32,236)", ""], ["Other comprehensive income/(loss)", "1,866", "", "", "1,866"], ["Ending balances at Mar. 30, 2019", "$ 105,860", "42,801", "64,558", "(1,499)"], ["Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)", "$ 1.46", "", "", ""], ["Beginning balances at Dec. 29, 2018", "$ 117,892", "40,970", "80,510", "(3,588)"], ["Common stock issued", "", "390", "", ""], ["Common stock withheld related to net share settlement of equity awards", "", "(105)", "(14)", ""], ["Share-based compensation", "", "1,546", "", ""], ["Net income", "11,561", "", "11,561", ""], ["Dividends and dividend equivalents declared", "", "", "(3,499)", ""], ["Common stock repurchased", "", "", "(24,000)", ""], ["Other comprehensive income/(loss)", "2,089", "", "", "2,089"], ["Ending balances at Mar. 30, 2019", "$ 105,860", "42,801", "64,558", "(1,499)"], ["Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)", "$ 0.73", "", "", ""], ["Beginning balances at Sep. 28, 2019", "$ 90,488", "45,174", "45,898", "(584)"], ["Common stock issued", "", "430", "", ""], ["Common stock withheld related to net share settlement of equity awards", "", "(1,052)", "(632)", ""], ["Share-based compensation", "", "3,480", "", ""], ["Net income", "33,485", "", "33,485", ""], ["Dividends and dividend equivalents declared", "", "", "(6,917)", ""], ["Common stock repurchased", "(38,500)", "", "(38,516)", ""], ["Other comprehensive income/(loss)", "(2,341)", "", "", "(2,341)"], ["Ending balances at Mar. 28, 2020", "$ 78,425", "48,032", "33,182", "(2,789)"], ["Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)", "$ 1.54", "", "", ""], ["Beginning balances at Dec. 28, 2019", "$ 89,531", "45,972", "43,977", "(418)"], ["Common stock issued", "", "428", "", ""], ["Common stock withheld related to net share settlement of equity awards", "", "(101)", "(96)", ""], ["Share-based compensation", "", "1,733", "", ""], ["Net income", "11,249", "", "11,249", ""], ["Dividends and dividend equivalents declared", "", "", "(3,432)", ""], ["Common stock repurchased", "", "", "(18,516)", ""], ["Other comprehensive income/(loss)", "(2,371)", "", "", "(2,371)"], ["Ending balances at Mar. 28, 2020", "$ 78,425", "$ 48,032", "$ 33,182", "$ (2,789)"], ["Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)", "$ 0.77", "", "", ""]]}, {"headers": [["CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Millions", "6 Months Ended"], ["Mar. 28, 2020", "Mar. 30, 2019"]], "sections": ["Statement of Cash Flows [Abstract]", "Operating activities:", "Adjustments to reconcile net income to cash generated by operating activities:", "Changes in operating assets and liabilities:", "Investing activities:", "Financing activities:", "Supplemental cash flow disclosure:"], "data": [["Cash, cash equivalents and restricted cash, beginning balances", "$ 50,224", "$ 25,913"], ["Net income", "33,485", "31,526"], ["Depreciation and amortization", "5,602", "6,435"], ["Share-based compensation expense", "3,407", "3,073"], ["Deferred income tax benefit", "(651)", "(124)"], ["Other", "(259)", "(215)"], ["Accounts receivable, net", "7,284", "8,094"], ["Inventories", "699", "(1,006)"], ["Vendor non-trade receivables", "7,923", "14,616"], ["Other current and non-current assets", "(8,866)", "(717)"], ["Accounts payable", "(13,520)", "(20,024)"], ["Deferred revenue", "1,223", "(540)"], ["Other current and non-current liabilities", "7,500", "(3,273)"], ["Cash generated by operating activities", "43,827", "37,845"], ["Purchases of marketable securities", "(66,489)", "(13,854)"], ["Proceeds from maturities of marketable securities", "39,738", "16,880"], ["Proceeds from sales of marketable securities", "27,762", "22,635"], ["Payments for acquisition of property, plant and equipment", "(3,960)", "(5,718)"], ["Payments made in connection with business acquisitions, net", "(1,134)", "(291)"], ["Purchases of non-marketable securities", "(146)", "(490)"], ["Other", "(426)", "30"], ["Cash generated by/(used in) investing activities", "(4,655)", "19,192"], ["Proceeds from issuance of common stock", "430", "390"], ["Payments for taxes related to net share settlement of equity awards", "(1,566)", "(1,427)"], ["Payments for dividends and dividend equivalents", "(6,914)", "(7,011)"], ["Repurchases of common stock", "(39,280)", "(32,498)"], ["Proceeds from issuance of term debt, net", "2,210", "0"], ["Repayments of term debt", "(5,250)", "(2,500)"], ["Proceeds from/(Repayments of) commercial paper, net", "1,518", "(36)"], ["Proceeds from repurchase agreement", "2,556", "0"], ["Other", "(51)", "(51)"], ["Cash used in financing activities", "(46,347)", "(43,133)"], ["Increase/(Decrease) in cash, cash equivalents and restricted cash", "(7,175)", "13,904"], ["Cash, cash equivalents and restricted cash, ending balances", "43,049", "39,817"], ["Cash paid for income taxes, net", "7,505", "9,497"], ["Cash paid for interest", "$ 1,689", "$ 1,762"]]}]